On October 22, the Engelberg Center for Health Care Reform hosted a roundtable webinar, “Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near Real-Time: Learnings from PRISM.”
The roundtable featured presentations from key experts on lessons learned from the implementation of the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) project, a coordinated federal strategy to monitor the safety of the 2009 H1N1 influenza vaccine using observational data from large health plans. Presenters provided an overview of PRISM and project conclusions, and described technical findings related to data infrastructure and methodological approaches. Discussion also focused on plans to integrate PRISM with the Mini-Sentinel active surveillance system.
Dan Salmon PhD, MPH; National Vaccine Program Office, U.S. Department and Health and Human Services, Washington, DC
Robert Ball MD, MPH; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD;
Richard Platt MD, MSc; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA